PROVIDER PROFILE · NPI 1023593332
Muyiwa Babarinde
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
1,151
Beneficiaries
—
Total drug cost
$112K
Distinct drugs
32
Brand share
16.1%
Top prescribed drugs
Atorvastatin Calcium223 claims
Metformin Hcl110 claims
Amlodipine Besylate90 claims
Losartan Potassium64 claims
Lisinopril64 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CROSS-REFERENCE